1. 1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis. Issue 10025 (26th March 2016) Authors: Stone, Gregg W; Gao, Runlin; Kimura, Takeshi; Kereiakes, Dean J; Ellis, Stephen G; Onuma, Yoshinobu; Cheong, Wai-Fung; Jones-McMeans, Jennifer; Su, Xiaolu; Zhang, Zhen; Serruys, Patrick W Journal: Lancet Issue: Volume 387:Issue 10025(2016) Page Start: 1277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy. Issue 10096 (19th August 2017) Authors: Ali, Ziad A; Serruys, Patrick W; Kimura, Takeshi; Gao, Runlin; Ellis, Stephen G; Kereiakes, Dean J; Onuma, Yoshinobu; Simonton, Charles; Zhang, Zhen; Stone, Gregg W Journal: Lancet Issue: Volume 390:Issue 10096(2017) Page Start: 760 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial. Issue 17 (23rd February 2013) Authors: Leonardi, Sergio; Truffa, Adriano A M; Neely, Megan L; Tricoci, Pierluigi; White, Harvey D; Gibson, C Michael; Wilson, Matthew; Stone, Gregg W; Harrington, Robert A; Bhatt, Deepak L; Mahaffey, Kenneth W Journal: Heart Issue: Volume 99:Issue 17(2013) Page Start: 1282 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ABSORB IV: will the low rate of scaffold thrombosis persist? – Authors' reply. Issue 10189 (15th June 2019) Authors: Stone, Gregg W; Ellis, Stephen G; Kereiakes, Dean J Journal: Lancet Issue: Volume 393:Issue 10189(2019) Page Start: 2392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. Issue 10317 (11th December 2021) Authors: Xu, Bo; Tu, Shengxian; Song, Lei; Jin, Zening; Yu, Bo; Fu, Guosheng; Zhou, Yujie; Wang, Jian'an; Chen, Yundai; Pu, Jun; Chen, Lianglong; Qu, Xinkai; Yang, Junqing; Liu, Xuebo; Guo, Lijun; Shen, Chengxing; Zhang, Yaojun; Zhang, Qi; Pan, Hongwei; Fu, Xiaogang Journal: Lancet Issue: Volume 398:Issue 10317(2021) Page Start: 2149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bioprosthetic surgical and transcatheter heart valve thrombosis. Issue 10087 (17th June 2017) Authors: Bax, Jeroen J; Stone, Gregg W Journal: Lancet Issue: Volume 389:Issue 10087(2017) Page Start: 2352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Bivalirudin in acute myocardial infarction: NICE guidance. Issue 6 (1st February 2012) Authors: Stone, Gregg W Journal: Heart Issue: Volume 98:Issue 6(2012) Page Start: 435 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial. Issue 10366 (26th November 2022) Authors: Li, Yi; Liang, Zhenyang; Qin, Lei; Wang, Mian; Wang, Xianzhao; Zhang, Huanyi; Liu, Yin; Li, Yan; Jia, Zhisheng; Liu, Limin; Zhang, Hongyan; Luo, Jun; Dong, Songwu; Guo, Jincheng; Zhu, Hengqing; Li, Shengli; Zheng, Haijun; Liu, Lijun; Wu, Yanqing; Zhong, Yiming Journal: Lancet Issue: Volume 400:Issue 10366(2022) Page Start: 1847 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: An updated meta-analysis of 10, 350 patients from five randomized clinical trials. Issue 3 (June 2016) Authors: Capodanno, Davide; Gargiulo, Giuseppe; Capranzano, Piera; Mehran, Roxana; Tamburino, Corrado; Stone, Gregg W Journal: European heart journal Issue: Volume 5:Issue 3(2016) Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: An updated meta-analysis of 10, 350 patients from five randomized clinical trials. Issue 3 (1st June 2016) Authors: Capodanno, Davide; Gargiulo, Giuseppe; Capranzano, Piera; Mehran, Roxana; Tamburino, Corrado; Stone, Gregg W Journal: European heart journal Issue: Volume 5:Issue 3(2016) Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗